PRL 3195
PRL 3195 is a selective somatostatin receptor antagonist with highest affinity for the human sst5 receptor (Ki=6 nM) . It is a valuable research tool for investigating somatostatin signaling in endocrine disorders and cancer, applicable in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Molecular Weight
1177.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog